Circular RNA vaccines against SARS-CoV-2 and emerging variants

被引：423

作者：

Qu, Liang ^{[1
]}

Yi, Zongyi ^{[1
,2
]}

Shen, Yong ^{[1
,2
]}

Lin, Liangru ^{[1
]}

Chen, Feng ^{[1
,2
]}

Xu, Yiyuan ^{[1
]}

Wu, Zeguang ^{[1
]}

Tang, Huixian ^{[1
]}

Zhang, Xiaoxue ^{[1
,2
]}

Tian, Feng ^{[1
]}

Wang, Chunhui ^{[1
]}

Xiao, Xia ^{[3
,4
,10
]}

Dong, Xiaojing ^{[3
,4
,10
]}

Guo, Li ^{[3
,4
,10
]}

Lu, Shuaiyao ^{[5
]}

Yang, Chengyun ^{[2
]}

Tang, Cong ^{[5
]}

Yang, Yun ^{[5
]}

Yu, Wenhai ^{[5
]}

Wang, Junbin ^{[5
]}

Zhou, Yanan ^{[5
]}

Huang, Qing ^{[5
]}

Yisimayi, Ayijiang ^{[6
]}

Liu, Shuo ^{[7
,8
]}

Huang, Weijin ^{[7
,8
]}

Cao, Yunlong ^{[6
]}

Wang, Youchun ^{[1
]}

Zhou, Zhuo ^{[1
]}

Peng, Xiaozhong ^{[5
,9
]}

Wang, Jianwei ^{[3
,4
,10
]}

Xie, Xiaoliang Sunney ^{[6
]}

Wei, Wensheng ^{[1
]}

机构：

[1] Peking Univ, Peking Univ Genome Editing Res Ctr,Peking Tsinghu, Sch Life Sci,Beijing Adv Innovat Ctr Genom, State Key Lab Prot & Plant Gene Res,Biomed Pionee, Beijing 100871, Peoples R China

[2] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, Christophe Merieux Lab, Beijing 100730, Peoples R China

[5] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Natl Kunming High Level Biosafety Primate Res Ctr, Kunming, Yunnan, Peoples R China

[6] Peking Univ, Biomed Pioneering Innovat Ctr, Beijing Adv Innovat Ctr Genom, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China

[7] Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, Beijing 102629, Peoples R China

[8] WHO Collaborating Ctr Standardizat & Evaluat Biol, Beijing 102629, Peoples R China

[9] Chinese Acad Med Sci, Sch Basic Med,Dept Mol Biol & Biochem, Peking Union Med Coll,State Key Lab Med Mol Biol, Med Primate Res Ctr,Neurosci Ctr,Inst Basic Med S, Beijing 100730, Peoples R China

[10] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Resp Dis Pathogen, Beijing 100730, Peoples R China

来源：

CELL | 2022年 / 185卷 / 10期

基金：

美国国家科学基金会; 国家重点研发计划;

关键词：

ANTIBODY-DEPENDENT ENHANCEMENT; POTENT; INFECTION; IMMUNOGENICITY; COVID-19; DESIGN; DRIVEN; SAFETY; ACE2;

D O I：

10.1016/j.cell.2022.03.044

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

As the emerging variants of SARS-CoV-2 continue to drive the worldwide pandemic, there is a constant demand for vaccines that offer more effective and broad-spectrum protection. Here, we report a circular RNA (circRNA) vaccine that elicited potent neutralizing antibodies and T cell responses by expressing the trimeric RBD of the spike protein, providing robust protection against SARS-CoV-2 in both mice and rhesus macaques. Notably, the circRNA vaccine enabled higher and more durable antigen production than the 1m Psi-modified mRNA vaccine and elicited a higher proportion of neutralizing antibodies and distinct Th1-skewed immune responses. Importantly, we found that the circRNA(RBD)(-Omicron) vaccine induced effective neutralizing antibodies against the Omicron but not the Delta variant. In contrast, the circRNA(RBD)(-Delta) vaccine protected against both Delta and Omicron or functioned as a booster after two doses of either native-or Delta-specific vaccination, making it a favorable choice against the current variants of concern (VOCs) of SARS-CoV-2.

引用

页码：1728 / +

页数：34

共 99 条

[61]

Mullard A, 2020, LANCET, V395, P1751, DOI 10.1016/S0140-6736(20)31252-6

[62] Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV [J].

Ou, Xiuyuan ;

Liu, Yan ;

Lei, Xiaobo ;

Li, Pei ;

Mi, Dan ;

Ren, Lili ;

Guo, Li ;

Guo, Ruixuan ;

Chen, Ting ;

Hu, Jiaxin ;

Xiang, Zichun ;

Mu, Zhixia ;

Chen, Xing ;

Chen, Jieyong ;

Hu, Keping ;

Jin, Qi ;

Wang, Jianwei ;

Qian, Zhaohui .

NATURE COMMUNICATIONS, 2020, 11 (01)

[63]

Papanikolopoulou Katerina, 2008, V474, P15, DOI 10.1007/978-1-59745-480-3_2

[64] mRNA vaccines - a new era in vaccinology [J].

Pardi, Norbert ;

Hogan, Michael J. ;

Porter, Frederick W. ;

Weissman, Drew .

NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (04) :261-279

[65] Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination [J].

Pardi, Norbert ;

Hogan, Michael J. ;

Pelc, Rebecca S. ;

Muramatsu, Hiromi ;

Andersen, Hanne ;

DeMaso, Christina R. ;

Dowd, Kimberly A. ;

Sutherland, Laura L. ;

Scearce, Richard M. ;

Parks, Robert ;

Wagner, Wendeline ;

Granados, Alex ;

Greenhouse, Jack ;

Walker, Michelle ;

Willis, Elinor ;

Yu, Jae-Sung ;

McGee, Charles E. ;

Sempowski, Gregory D. ;

Mui, Barbara L. ;

Tam, Ying K. ;

Huang, Yan-Jang ;

Vanlandingham, Dana ;

Holmes, Veronica M. ;

Balachandran, Harikrishnan ;

Sahu, Sujata ;

Lifton, Michelle ;

Higgs, Stephen ;

Hensley, Scott E. ;

Madden, Thomas D. ;

Hope, Michael J. ;

Kariko, Katalin ;

Santra, Sampa ;

Graham, Barney S. ;

Lewis, Mark G. ;

Pierson, Theodore C. ;

Haynes, Barton F. ;

Weissman, Drew .

NATURE, 2017, 543 (7644) :248-+

[66] Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization [J].

Planas, Delphine ;

Veyer, David ;

Baidaliuk, Artem ;

Staropoli, Isabelle ;

Guivel-Benhassine, Florence ;

Rajah, Maaran Michael ;

Planchais, Cyril ;

Porrot, Francoise ;

Robillard, Nicolas ;

Puech, Julien ;

Prot, Matthieu ;

Gallais, Floriane ;

Gantner, Pierre ;

Velay, Aurelie ;

Le Guen, Julien ;

Kassis-Chikhani, Najiby ;

Edriss, Dhiaeddine ;

Belec, Laurent ;

Seve, Aymeric ;

Courtellemont, Laura ;

Pere, Helene ;

Hocqueloux, Laurent ;

Fafi-Kremer, Samira ;

Prazuck, Thierry ;

Mouquet, Hugo ;

Bruel, Timothee ;

Simon-Loriere, Etienne ;

Rey, Felix A. ;

Schwartz, Olivier .

NATURE, 2021, 596 (7871) :276-+

[67] Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies [J].

Planas, Delphine ;

Bruel, Timothee ;

Grzelak, Ludivine ;

Guivel-Benhassine, Florence ;

Staropoli, Isabelle ;

Porrot, Francoise ;

Planchais, Cyril ;

Buchrieser, Julian ;

Rajah, Maaran Michael ;

Bishop, Elodie ;

Albert, Melanie ;

Donati, Flora ;

Prot, Matthieu ;

Behillil, Sylvie ;

Enouf, Vincent ;

Maquart, Marianne ;

Smati-Lafarge, Mounira ;

Varon, Emmanuelle ;

Schortgen, Frederique ;

Yahyaoui, Layla ;

Gonzalez, Maria ;

De Seze, Jerome ;

Pere, Helene ;

Veyer, David ;

Seve, Aymeric ;

Simon-Loriere, Etienne ;

Fafi-Kremer, Samira ;

Stefic, Karl ;

Mouquet, Hugo ;

Hocqueloux, Laurent ;

van der Werf, Sylvie ;

Prazuck, Thierry ;

Schwartz, Olivier .

NATURE MEDICINE, 2021, 27 (05) :917-+

[68] The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design [J].

Rey, Felix A. ;

Stiasny, Karin ;

Vaney, Marie-Christine ;

Dellarole, Mariano ;

Heinz, Franz X. .

EMBO REPORTS, 2018, 19 (02) :206-224

[69] Modified mRNA Vaccines Protect against Zika Virus Infection [J].

Richner, Justin M. ;

Himansu, Sunny ;

Dowd, Kimberly A. ;

Butler, Scott L. ;

Salazar, Vanessa ;

Fox, Julie M. ;

Julander, Justin G. ;

Tang, William W. ;

Shresta, Sujan ;

Pierson, Theodore C. ;

Ciaramella, Giuseppe ;

Diamond, Michael S. .

CELL, 2017, 168 (06) :1114-+

[70] SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung [J].

Routhu, Nanda Kishore ;

Cheedarla, Narayanaiah ;

Bollimpelli, Venkata Satish ;

Gangadhara, Sailaja ;

Edara, Venkata Viswanadh ;

Lai, Lilin ;

Sahoo, Anusmita ;

Shiferaw, Ayalnesh ;

Styles, Tiffany M. ;

Floyd, Katharine ;

Fischinger, Stephanie ;

Atyeo, Caroline ;

Shin, Sally A. ;

Gumber, Sanjeev ;

Kirejczyk, Shannon ;

Dinnon, Kenneth H. ;

Shi, Pei-Yong ;

Menachery, Vineet D. ;

Tomai, Mark ;

Fox, Christopher B. ;

Alter, Galit ;

Vanderford, Thomas H. ;

Gralinski, Lisa ;

Suthar, Mehul S. ;

Amara, Rama Rao .

NATURE COMMUNICATIONS, 2021, 12 (01)

← 1 2 3 4 5 6 7 8 9 10 →